Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...

Gilead Sciences and Arcus Biosciences said on Friday they would stop a late-stage study testing their experimental cancer ...

Finding the best blue-chip stocks to buy is never a simple task, especially when markets are shifting. Economic uncertainty, changing interest-rate expectations and the rapid evolution of ...

Gilead is hoping to break ground early next year on its Chess Hatch campus as part of its plans to expand its presence in ...

Gilead Sciences stock has seen its fair value estimate edge down only slightly, from about $130.83 to $130.63, even as the discount rate nudged up from roughly 7.26% to 7.29% and long term revenue ...

Gilead Sciences (GILD) just got a confidence boost from Wall Street, with Truist initiating coverage at Buy and Mizuho ...

Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsAndrew Dickinson - ...

BAY AREA LEADERS AND GAY RIGHTS advocates gathered in San Francisco to honor community members and commemorate World AIDS Day.  Tweed suits and feathered Bay Area leaders and LGBTQ advocates gathered ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...

Physicians at Northwell Health’s Sexual Health Program, part of North Shore University Hospital, are drawing attention to the persistently high rates of sexually transmitted infections (STI) across ...

A new manufacturing process is on track to make developing HIV-prevention medication more affordable and potentially decrease new HIV infections in hard-hit countries.